UBS raised the firm’s price target on Li-Cycle (LICY) to $2.25 from $2 and keeps a Neutral rating on the shares post the Q3 report.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.